November 3-5, 2019

We respect and appreciate your opinions. To assist us in evaluating the effectiveness of this activity and to make recommendations for the future educational offerings, please take a few minutes to complete this evaluation form.

If you wish to receive CME/CEU credit for this activity, please complete this evaluation.

Question Title

* 1. First Name

Question Title

* 2. Last Name

Question Title

* 3. Email (Your CME/CEU or Genetic CEU certificate will be sent to this email)

Question Title

* 4. What best describes your speciality?

Question Title

* 5. How well did this activity meet the following learning objectives?

  Poor Fair Satisfactory Good Excellent
Summarize recent research on the basic biology of colorectal cancer development, including modifiers of the hereditary phenotypes
Describe potential implications for clinical practice
Implement new approaches to screening and preventing colorectal cancers
Summarize the evidence for new diagnostics, devices, and pharmaceuticals
Describe the impact of newly discovered genes and the use of recently introduced gene panels to diagnose and manage hereditary colorectal cancer syndromes
Institute use of clinical and genetic modifiers of the hereditary cancer risk in their clinical practice
Define the changing care models for diagnosis and management of various hereditary cancer syndromes
List the surgical approaches to hereditary colorectal cancer syndromes for both treatment and prophylaxis 
Describe patient criteria for referral for surgery that offers optimal outcomes

Question Title

* 6. Please comment if any of the above objectives were not met.

T